EP Patent
EP1670482A1 — Use of ciclesonide for the treatment of respiratory diseases
Assigned to Covis Pharma Bv · Expires 2006-06-21 · 20y expired
What this patent protects
This invention relates to a new method of treatment of respiratory diseases, in particular the treatment of asthmatic children.
USPTO Abstract
This invention relates to a new method of treatment of respiratory diseases, in particular the treatment of asthmatic children.
Drugs covered by this patent
- Omnaris (CICLESONIDE) · Covis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.